|
Study | Study design | Antioxidant and other supplements studied | Effect on NMSC risk | Statistically significant results | Study location |
|
Frieling et al., 2000 [35] | RCT of 22,071 male physicians over 12 years | 50 mg beta-carotene, QOD | None | NA | USA |
| | | | | |
Duffield-Lillico et al., 2003 [36] | RCT of 1312 patients with previous NMSC over 10 years | 200 mcg selenium, QD | BCC: none SCC: increased risk | BCC: NA SCC: RR: 1.14; 95% CI, 0.93–1.39 | USA |
| | | | | |
Reid et al., 2008 [37] |
RCT of 424 adults followed for 6 years, and a subset of 315 adults in the NPC study [37] | 200 mcg selenium NPC subset, QD | NMSC: increased risk | 200 mcg cohort: RR: 1.49; 95% CI: 1.10–2.03; : 0.008 |
USA |
400 mcg selenium, QD | None | NA |
| | | | | |
Greenberg et al., 1990 [38] | RCT of 1805 patients with history of NMSC over 5 years | 50 mg beta-carotene, QD | None | RR: 1.05; 95% CI, 0.91–1.22 | USA |
| | | | | |
Hercberg et al., 2007 [39] | RCT of 13,017 adults followed over median of 7.5 years | Daily combination of: 120 mg vitamin C 30 mg vitamin E 6 mg beta-carotene 100 mcg selenium 20 mg zinc | BCC: none SCC: increased risk in women | BCC: NA SCC: Women: aHR: 1.68; : 0.03 | France |
| | | | | |
Vinceti et al., 2014 [40] | Meta-analysis which included 3 RCTs of NMSC | Selenium+ | NMSC: increased risk | RR: 1.44; 95% CI: 0.95–1.17 | Asia, Europe, US, and Australia |
| | | | | |
Chang et al., 2011 [41] | Meta-analysis of 10 RCTs | Vitamin A+ Vitamin C+ Vitamin E+ B-carotene+ | None | NA | USA, Netherlands, Australia, UK, and Canada |
|